S
teroidogenic factor 1 (SF-1, designated NR5A1) is a member of the nuclear receptor superfamily that plays critical roles throughout the hypothalamic-pituitary-steroidogenic organ axes (1) . SF-1 knockout (KO) mice have adrenal and gonadal agenesis (2-4) and marked structural abnormalities of the ventromedial hypothalamic nucleus (VMH) (5) (6) (7) (8) (9) . The restricted neuronal expression of SF-1 only in the VMH in the mammalian brains suggests that it plays important roles in VMH function. Global (SF-1 Ϫ/Ϫ ) and central nervous system (CNS)-specific SF-1 knockout (SF-1 KO nCre;F/Ϫ ) mice exhibited multiple VMH defects, including late-onset obesity, decreased locomotor activity, and increased anxiety (7, 8, 10, 11) and aggression (12) . However, the roles of SF-1 in the regulation of reproductive function in the VMH are poorly understood. In vertebrates, reproduction requires complex, reciprocal interactions among the components of the hypothalamic-pituitary-gonadal axis. GnRH is released in pulses from terminals in the median eminence (ME) of the hypothalamus. The GnRH pulses, in turn, stimulate pituitary gonadotropes to secrete the gonadotropins, LH and FSH. Finally, the gonadotropins regulate gonadal function, including the synthesis and secretion of sex steroids. Because of the complexity of mammalian reproduction, infertility could be connected with any factor affecting the GnRH pulses or gonadotropin secretion (13) (14) (15) .
The VMH regulates a variety of functions, including food intake, locomotion, and reproductive function (16, 17) . For example, regional infusion and lesion studies have shown that the VMH is a critical hypothalamic site for female sexual behavior in rodents (18) . In addition, steroid receptors, such as progesterone receptor (PR) and estrogen receptor (ER)␣ and -␤, are expressed in the VMH (19, 20) . The cells containing immunoreactive ER␣ are located in stereotyped positions in the ventrolateral portion of the nucleus, but these cells are located more medially in SF-1 KO mice (5) . Thus, the VMH is an important brain region for the integration of steroid signals (21) (22) (23) .
We previously showed that specific inactivation of SF-1 in the CNS altered neuronal positions in and around the VMH and particularly changed the location of ER␣-positive neurons in the ventrolateral region of the VMH (5, 8 -10) . We hypothesized that alterations in either the locations of hormone receptor-containing cells and/or the expression of steroid hormone receptors in cells of the VMH may cause alterations in estrogen and progesterone feedback with neural and sensory cues that regulate reproduction. To address this possibility, we used mice in which the Cre/loxP technology was introduced to generate mice selectively lacking SF-1 in the VMH neurons. In the present study, we show that female SF-1 KO nCre;F/Ϫ mice have markedly impaired follicle development, fertility, and sexual behaviors, most likely due to primary influences and secondary consequences of brainselective SF-1 disruption, delineating crucial roles of SF-1 in the CNS.
Results
Decreased fertility in SF-1 KO nCre;F/؊ females To assess potential reproductive alterations in the SF-1 KO nCre;F/Ϫ mice, we first examined fertility in age-and sex-matched mice. During 6 months of breeding, SF-1 KO nCre;F/Ϫ females showed infertile or subfertile phenotypes. Ten of 18 SF-1 KO nCre;F/Ϫ female mice were infertile (55.6%), and the remaining eight females were subfertile (Table 1) org). However, as shown in Table 1 , the total number of pups from SF-1 KO nCre;F/Ϫ females was significantly decreased (65 pups delivered by 18 SF-1 KO nCre;F/Ϫ mothers, 3.6 pups per mother, and 438 pups delivered by 15 WT females, 29.2 pups per mother; P Ͻ 0.05). None of the female SF-1 KO nCre;F/Ϫ mice bore a fourth litter. More than half of the mice never became pregnant during the observation period. There was no difference in body weight between WT and SF-1 KO nCre;F/Ϫ mice. These results highlight that SF-1 plays an important role in regulation of female fertility independent of influences on energy balance (7) .
Failure of follicular maturation and ovulation is frequently accompanied by a disordered estrous cycle (24) . To dissect a possible mechanism of impaired fertility in SF-1 KO nCre;F/Ϫ mice, we examined estrous cycles in both SF-1 KO nCre;F/Ϫ and WT littermates. In WT mice, the estrous cycle progressed regularly, lasting 4 -5 d at both 2 and 6 months of age ( Fig. 1 and Supplemental  Fig. 2 ). Although there was individual variation, female SF-1 KO nCre;F/Ϫ mice displayed significantly disordered estrous cycles. Specifically, prolonged diestrous and estrous phases were observed in SF-1 KO nCre;F/Ϫ mice at 2 and 6 months of age ( Fig. 1 and Supplemental Fig. 2 ).
Anatomy and histology of the reproductive organs in SF-1 KO nCre;F/؊ mice We previously reported that SF-1-expressing tissues outside of the CNS appeared intact in SF-1 KO nCre;F/Ϫ mice and that they retained SF-1 expression (8). To explore possible reasons for their impaired fertility, we extended these studies. Examination of the reproductive organs revealed a reduced ovary weight relative to body weight in the SF-1 KO nCre;F/Ϫ females compared with WT controls (Table 2 ). In contrast, the size of the uterus in SF-1 KO nCre;F/Ϫ mice was normal (data not shown). (Table 3 ). These data indicate that the ovaries of SF-1 KO nCre;F/Ϫ mice can respond normally to gonadotropins and suggest that their reduced fertility is likely due to impairment at higher levels. Analysis of higher levels of the reproductive axis in SF-1 KO nCre;F/؊ mice We next examined the function of pituitary gonadotropes in the SF-1 KO nCre;F/Ϫ mice. As shown in Fig. 3 , A and B, the basal levels of plasma LH and FSH were not significantly differ in WT and SF-1 KO nCre;F/Ϫ mice. Similarly, no significant differences were observed in circulating levels of estradiol (E2) (females, Fig. 3C ) or testosterone (males, Supplemental Table 1 ). These results suggest that the SF-1 KO nCre;F/Ϫ mice do not have a severe deficiency of gonadotropins that might impair both sex steroid production and fertility. However, because of the impaired estrous cycle of the SF-KO nCre;F/Ϫ mice, it remains entirely possible that they fail to mount the midcycle LH surge that normally triggers ovulation. In addition, basal progesterone levels were significantly decreased in SF-1 KO nCre;F/Ϫ mice, consistent with a lack or decreased number of CL in the SF-1 KO nCre;F/Ϫ mice (Fig. 3D ). To examine more directly the production of gonadotropins by the gonadotropes, we used immunohistochemistry to provide a semiquantitative assessment of levels of LH and FSH in the gonadotropes. As shown in Fig. 4 , the levels of immunoreactive LH and FSH were similar in pituitary sections from WT and SF-1 KO nCre;F/Ϫ mice. These findings, which are consistent with the measurements of circulating gonadotropins (Fig. 3, A and B) , again argue that the gonadotropes are intrinsically intact in the SF-1 KO nCre; F/Ϫ mice.
As a dynamic test of gonadotrope function, we measured LH secretion in response to serial injections with E2 and P followed by stimulation with the GnRH agonist buserelin (Fig. 3A) . To exclude any feedback effects from the ovaries, ovariectomized mice were used. Like mice with intact ovaries, basal levels of LH were comparable between WT and SF-1 KO nCre;F/Ϫ mice (Fig. 3A) . Upon Stimulation, SF-1 KO nCre;F/Ϫ mice displayed a significant increase in LH secretion (Fig. 3A) . However, the increase of buserelin-induced LH level was significantly blunted in SF-1 KO nCre;F/Ϫ compared with WT mice (Fig.  3A) . This suggests that the gonadotropes in SF-1 KO nCre;F/Ϫ mice still maintain their ability to secrete the gonadotropin in response to upstream signals, but the SF-1 KO nCre;F/Ϫ mice cannot develop the full capacity to secrete LH similar to WT controls, likely due to the impaired priming process in SF-1 KO nCre;F/Ϫ females. In sum, these studies all indicate that the fertility defect observed in SF-1 KO nCre;F/Ϫ mice is most likely secondary to a central defect, including an abnormal priming process and dysfunction in gonadotropes.
We further found that basal prolactin (PRL) levels in Mice were stimulated with PMSG at 3 or 10 wk of age, and the oocytes were harvested from the oviducts and counted as described in Materials and Methods. 
SF-1 KO
nCre;F/Ϫ mice were markedly elevated compared with WT controls (Fig. 3E ). Because the primary regulation of PRL release from the anterior pituitary gland is mediated by the inhibitory tone of dopamine secreted from the ME and periventricular nuclei of the hypothalamus, we first did immunohistochemical analysis for tyrosine hydroxylase (TH), a rate-limiting enzyme for dopamine synthesis, to determine whether there was a change in TH neurons in the hypothalamus. The immunohistochemical analysis revealed that the distribution of TH neurons in the anterior and mediobasal hypothalamic area including the VMH showed no obvious difference between SF-1 KO nCre;F/Ϫ and WT counterparts (data not shown). However, when bromocriptine (25), a dopamine receptor agonist, was administered (Fig. 3E) Fig. 3 ). Because the morphology of PRL cells in the pituitary was ostensibly normal, and the defect was in functional responsiveness to dopamine, it is possible that the reorganization of the mediobasal hypothalamus in SF-1 KO nCre;F/Ϫ mice contributed to developmental changes in hypothalamic-pituitary regulatory function at molecular levels not revealed at anatomical levels.
Effect of SF-1 inactivation on hypothalamic structure and expression of steroid hormone receptors
Based on our previous studies of SF-1 inactivation in the brain demonstrating that SF-1 plays a crucial role in neuronal positioning in and around the VMH both intrinsically and extrinsically (5, 8 -11) , we next examined different aspects of SF-1 function in the hypothalamus. We first examined GnRH expression in the ME using immunofluorescence from WT and SF-1 KO nCre;F/Ϫ mice. For these studies, we used a SF-1/eGFP transgene (26) to mark the neurons that normally express SF-1 (Fig.  5A) . Inactivation of SF-1 in the VMH exhibited marked dislocation of SF-1 neurons throughout the mediobasal hypothalamus (Fig. 5B) . However, immunoreactive GnRH in fibers and terminals showed similar localization at the level of the ME in both WT and SF-1 KO nCre;F/Ϫ mice, suggesting that the location and axonal delivery of the GnRH neurons might not be impaired by SF-1 inactivation (Fig. 5, A and B) .
Activation of PR and ER in the VMH influences many neuroendocrinological processes in female rodents, including preovulatory surges in gonadotropin secretion and female sexual behaviors. We previously demonstrated that ablation of SF-1 expression in the VMH caused a marked redistribution of ER␣-positive cells in the mediobasal hypothalamus (5, 6, 8) . Multiple studies have documented that E2 mediates induction of PR in the VMH, and its induction was blunted in ER␣ KO mice (20) and other models (27) (28) (29) , demonstrating a functional relationship between ER␣ and PR. We therefore hypothesized that the known structural perturbation of the VMH in SF-1 KO nCre;F/Ϫ mice, including marked effects on ER␣-expressing cells, might blunt the normal effect of E2 to induce PR expression and thereby block functional effects of progesterone. Ovariectomized WT and SF-1 KO nCre;F/Ϫ mice were injected with E2 benzoate (EB) or vehicle, followed by progesterone after 5 d as described in Materials and Methods. As shown in Fig. 5 , E and F, expression of ER␣ was markedly displaced in SF-1 KO nCre;F/Ϫ compared with WT littermates as we observed before (6 -8) . Notably, induction of immunoreactive PR in the ventrolateral region of the VMH, a steroid-responsive and integrative site, was markedly impaired in SF-1 KO nCre;F/Ϫ mice and displaced PR signal closer to the ventricle. This suggests that normal expression of SF-1 in the VMH plays a critical role in EB-induced PR expression in the region.
Decreased female sexual behavior in SF-1 KO nCre;F/؊ mice It is well established that activation of ER␣ in the VMH is directly related to lordosis behavior in rodent models and is a key step in the display of female sexual behavior (30 -33) . In this study, we found that SF-1 KO nCre;F/Ϫ mice showed similar copulatory plugs compared with WT controls measured for 26 d (Supplemental Fig. 1 ). Although we saw similar numbers of copulatory plugs examined for about 1 month, the impaired expression and activation of ER and PR in and around the VMH may still have affected female sexual behavior in SF-1 KO nCre;F/Ϫ mice in specific aspects of the pattern of behavior. Thus, we examined whether impaired reproduction seen in SF-1 KO nCre;F/Ϫ mice is due, at least in part, to the failure of expression of these receptors in the VMH. Lordosis quotient (Fig. 6, A, D, and G) , the percentage of proceptive/ still posture (Fig. 6, B and E) , and receptivity score (Fig. 6 , C and F) were measured in SF-1 KO nCre;F/Ϫ and WT littermates at 2 (Fig. 6, A-C) and 6 (Fig. 6, D-G) months of age. Although SF-1 KO nCre;F/Ϫ female mice showed no difference in the percentage of proceptive/still posture (Fig. 6 , B and E), they exhibited a significantly blunted lordosis quotient and receptivity compared with WT littermates (Fig. 6 , A, C, D, F, and G). All females including WT and SF-1 KO nCre;F/Ϫ mice from both age groups showed increasing sexual behavior correlated with numbers of experience, reaching maximal levels by trial 4 (Fig.  6G for 6 -month-old females or data not shown for 2-month-old females). However, SF-1 KO nCre;F/Ϫ female mice showed strikingly blunted lordosis quotient compared with WT littermates from trial 2 to the end of the trials (Fig. 6G) . These results suggest that SF-1 expression in the VMH is necessary for the development and display of normal female sexual behaviors.
Discussion
A number of studies now indicate that SF-1 plays crucial roles in the establishment of the cytoarchitecture of the VMH. In the current study, CNS-specific KO of SF-1 in female mice caused a complex reproductive phenotype that included impaired follicular maturation and decreases in lordosis, ovulation, and fertility. The ovaries of SF-1 KO nCre;F/Ϫ mice responded to exogenous gonadotropins, and the gonadotropes in ovariectomized SF-1 KO nCre;F/Ϫ mice secreted gonadotropin when stimulated with a GnRH agonist after priming with serial injections of E2 and progesterone. A recent paper described a population of stem cells in the pituitary that were nestin-cre expressing and suggested that a nestin-cre transgene could influence adult stem cells in the pituitary especially in somatotrophs and lactotrophs (34) . In the current study, SF-1 was expressed only in pituitary gonadotrophs and was not obviously affected by the nestin-cre transgene based on immunohistochemical observation. Although GnRH agonist treatment of SF-1 KO nCre;F/Ϫ mice did induce an LH surge, it was notably less robust that in WT mice, suggesting some potential deficits in pituitary function. This may not have been selective to gonadotropes in as much as bromocriptine's ability to decrease PRL secretion was also impaired. In the absence of histological evidence for changes in the pituitary, the loss of SF-1 in the brain may have the secondary consequence of influencing functional differentiation of the pituitary. The defect in reproduction, therefore, cannot be unambiguously tied to brain influences of SF-1.
Alterations in reproductive behaviors are likely mediated by the altered organization of the ventrolateral part of the VMH directly. The VMH has well defined projections to the medial central gray and periaqueductal gray regions that have been implicated in lordosis (16) . It is conceivable that the effects on reproduction by ablation of SF-1 in the VMH include both direct effects due to alterations in specific VMH neurons (lordosis) and indirect effects to the regional perturbation (GnRH release). Neurons of the ventrolateral part of the VMH may also transmit excitatory signals to GnRH neurons that may enhance neuroendocrine status (35, 36) and subsequent behavior.
The major masculinizing testicular hormone is testosterone, a steroid secreted from Leydig cells of the testes that promotes establishment of the male reproductive tract. The serum levels of testosterone were not significantly differed in SF-1 KO nCre;F/Ϫ and WT littermates. In addition, male reproductive behaviors such as mounting, intromission, and ejaculation were not changed in SF-1 KO nCre;F/Ϫ mice. There are many possible mechanisms that may explain the normal sexual behavior seen in SF-1 KO nCre;F/Ϫ male mice. One major reason may be attributed to androgen receptor (AR) actions. Although some reports have suggested that androgen activation in the VMH plays important roles in induction of motivational components of male sexual behavior (37) and in copulatory performance (38) , AR blockade in the medial preoptic area (MPOA) showed pronounced effects on the males' mounting, intromission, and ejaculating, because the MPOA has tradition- ally been linked to male copulatory performance (39 -41) . Therefore, it is entirely possible that ablation of SF-1 may not interfere with AR function in the MPOA, which may be more essential than the VMH for male reproduction.
The role of the VMH in feminine sexual behavior is established due to its expression of steroid receptors (23, 42) , the behavioral responses to the locally administered estrogens (43) , the impaired sexual behavior by VMH lesions (44, 45) , the facilitated lordosis reflex by electrical stimulation in the VMH (46) , and the efferent connections of the VMH underlying female reproductive behaviors (47) . Within the VMH, SF-1 plays an essential developmental role in establishing and maintaining morphological integrity for a functional nucleus. Therefore, ablation of SF-1 in the VMH might lead to abnormal functional connections of steroid hormone receptor-containing cells and impaired neural communications involved in female reproductive behaviors. Additionally, because a displacement of the position of cells in and around the VMH induced by SF-1 ablation may not attain its correct phenotypic identity and become properly connected, the disorganization of mediobasal hypothalamus will affect the expression and location of many neurochemical and endocrine markers in the mediobasal hypothalamus (5, 8, 9) . Indeed, we found aberrant locations for cells containing immunoreactive ER␣ in SF-1 KO nCre;F/Ϫ mice. Importantly, EBinduced PR expression was markedly impaired in SF-1 KO nCre;F/Ϫ mice, highly implying a requirement for the role of SF-1 for normal function of PR induction in the VMH.
Progesterone, a known component in the ovarian feedback regulation of gonadotropin secretion, exerts both positive and negative feedback effects. We found significantly decreased progesterone levels in SF-1 KO nCre;F/Ϫ mice. Although normal expression of SF-1 in KO ovaries may play a role in preservation of the expression of many genes encoding steroid biosynthesis enzymes, including direct target genes of SF-1 such as steroidogenic acute regulatory protein (StAR), cholesterol side-chain cleavage enzyme (CYP11A), and 3␤-hydroxysteroid dehydrogenase (3␤-HSD), a defect of the transient endocrine organ (CL), where progesterone is predominantly produced, in the SF-1 KO nCre;F/Ϫ may disrupt the normal production of progesterone as shown in Fig. 3D (48, 49) .
In the present study, slightly elevated basal circulating LH levels in SF-1 KO nCre;F/Ϫ females are consistent with their prolonged estrous phase (Figs. 1B and 3A) . However, basal FSH levels in serum were not different in SF-1 KO nCre;F/Ϫ compared with WT mice. Attenuation of PRmediated negative feedback at the VMH may result in an increase in the frequency and/or amplitude of the GnRH pulses. This situation may elicit higher basal LH release but still below a threshold of sensitivity to affect FSH release. In PR KO female mice, similarly, basal serum LH levels are significantly elevated, but FSH levels were unchanged, consistent with the presumed absence of progesterone negative feedback (50) . However, GnRH release patterns remains to be clarified due to the pending development of a method to directly monitor GnRH release in these mice.
We also observed significantly elevated PRL levels in SF-1 KO nCre;F/Ϫ mice. Normally, PRL secretion is inhibited by dopamine released from the hypothalamic neurons (51). Analysis of expression or localization of TH neurons in the hypothalamus revealed that the distribution of TH neurons in the VMH area was similar between SF-1 KO nCre;F/Ϫ and WT mice (data not shown). This result suggests that the biosynthesis and distribution of the TH was not affected by the deletion of SF-1 in the VMH. However, we found that SF-1 KO nCre;F/Ϫ mice showed significantly less inhibitory effect in PRL secretion compared with WT littermates when we injected bromocriptine, a dopamine receptor agonist. Together, these results imply that elevated PRL levels seen in SF-1 KO nCre;F/Ϫ may be due, at least in part, to loss of inhibitory tone of dopamine from the hypothalamus to the pituitary. In addition, other factors could affect the PRL elevation in SF-1 KO nCre;F/Ϫ mice. First, the observations in which progesterone plays a negative role in E2-induced PRL production and gene expression leads to the speculation that significantly lower levels of progesterone in SF-1 KO nCre;F/Ϫ mice could contribute to increase of PRL level in the mice (52) (53) (54) . Also, the disrupted PR signaling pathway in the VMH (50) or aberrant psychological stress might delineate the phenomenon (8, 55) seen in SF-1 KO nCre;F/Ϫ females. In summary, reproductive behavior in female animal models is elicited in response to appropriate physiological cues, including integration of neural connectivity and hormonal information. In this sense, our study provides new insight that a nuclear receptor, SF-1, plays crucial roles in the VMH for regulation of female reproduction, giving insight on functional involvement of SF-1 in neural mechanisms, especially by guiding normal development and establishment of the mediobasal hypothalamus including the VMH, delineating female sexual mechanisms. (8) . SF-1F/ϩ mice served as WT controls if the genotype is not indicated. The effect of nestin-cre transgene on expression of SF-1 has been described in our previous publications, especially in terms of SF-1 expression patterns in different tissues and ages (8, 10) . All mice were maintained on a 12-h light, 12-h dark cycle and were fed ad libitum with regular mouse chow (Teklad mouse/rat diet 7001; 3.82 kcal/g gross energy, 4.25% kcal from fat).
Materials and Methods

Mice
Fertility assessment
The female SF-1 KO nCre;F/Ϫ (n ϭ 18) or their WT littermates (n ϭ 15) aged 8 wk old were paired with sexually experienced WT males for 6 months. The number of pregnancies, number of mice per litter, and total number of pups were determined based on the number of pups on the morning after delivery. Because each animal showed a large variation of pregnant time and intervals, especially in SF-1 KO nCre;F/Ϫ mice, sequences of fertility assessment are not related to mother's age. To determine the frequency of sexual intercourse, WT and SF-1 KO nCre;F/Ϫ mice were paired with a normal adult of the opposite sex, and copulatory plug formation was examined daily in the early morning for 26 d.
Determination of estrous cycle
To determine the estrous cycle phase, vaginal smears from SF-1 KO nCre;F/Ϫ (n ϭ 9) and their WT littermates (n ϭ 9) aged 3 or 6 months were collected by rinsing the vagina with PBS at 1400 h. Collected smears were dried on slides and stained with Giemsa's solution. Proestrus was designated when the smear was occupied by largely small, round, nucleated epithelial cells with few leukocytes. An estrous phase was determined when the smear contained cornified cells (squames) with degenerated nuclei. When predominantly leukocytes were present, mice were in metestrus or diestrus (56) . These observations were performed for 21 consecutive days.
Superovulation
Follicular maturation was induced at 3 or 10 wk old in female SF-1 KO nCre;F/Ϫ (n ϭ 8; five mice aged 3 wk, three mice aged 10 wk) and WT littermates (n ϭ 9; five mice aged 3 wk, four mice aged 10 wk). The mice received ip injection of 5 U PMSG (Sigma Chemical Co., St. Louis, MO) at 1700 h on d 1 of the experiment, followed by ip injection of 5 U human chorionic gonadotropin (Sigma) at 1700 h on d 3 to induce ovulation. Released oocytes were collected from the oviduct and counted on d 4.
Hormone measurements
Animals aged from 2-4 months were used for all hormonal assessments when not specified. Basal levels of serum FSH and LH were measured from SF-1 KO nCre;F/Ϫ and WT littermates by using RIA reagents either from the National Hormone and Pituitary Program (Torrance, CA) or using LINCOplex kits from Linco Research, Inc. (St. Charles, MO). To measure LH level after GnRH agonist treatment, ovariectomized females received EB (1 g/mouse in sesame oil; Sigma) followed by a progesterone injection (500 g/mouse in sesame oil) 24 h before administration of the GnRH agonist buserelin (2 g in 100 l PBS with 0.3% BSA) or vehicle alone as described (57) . One hour later, serum was collected, and LH concentrations were determined by Dr. A. F. Parlow (Torrance, CA). E2 and testosterone concentrations were measured by Dr. David Hess (University of Oregon, Beaverton, OR). Basal E2 levels were measured in estrous phase. Progesterone levels were determined by the Ligand Assay and Analysis Core Laboratory (The University of Virginia, Charlottesville, VA). For determination of PRL level, blood was collected from WT and SF-1 KO nCre;F/Ϫ mice with or without ip injection of bromocriptine (300 g Sigma E2134) for 5 d, and hormone levels were measured with RIA or LINCOplex kits. Statistical significance was determined by the Student's t test, and differences with P Ͻ 0.05 were considered significant.
Histology and immunohistochemistry
Female WT and SF-1 KO nCre;F/Ϫ mice were anesthetized and then perfused transcardially with 4% paraformaldehyde. Ovaries were dissected and embedded with paraffin. Serial sectioning of ovaries was performed, and sections were stained with hematoxylin and eosin to determine the numbers of preovulatory follicles and CL. Rabbit antimouse SF-1 (1:1500) (10), anti-LH (1:10,000), FSH (1:10,000), and anti-PRL (1:5,000) antibodies were used for SF-1, LH, FSH, and PRL immunohistochemistry, respectively. Samples were incubated with a biotinconjugated antirabbit secondary antibody (1:1000) from Vector Laboratories (Burlingame, CA; BA-1000) for 2 h, followed by 1 h incubation with a solution of avidin-biotin complex (Vectastain Elite ABC kit; Vector). Finally, signals were visualized with DAB substrate kit (SK-4100; Vector).
For detection of PR and ER in the VMH, 20 ovariectomized mice, WT (n ϭ 10) and SF-1 KO nCre;F/Ϫ (n ϭ 10), were used. Mice were perfused with 4% paraformaldehyde in PBS (pH 7.4) buffer, and the brains were removed and immersed overnight in a 0.1 M phosphate buffer containing 30% sucrose. Serial coronal sections (40 m) were made through the forebrain. The sections were collected into cryoprotectant and stored at Ϫ20 C until use. Every fourth section was processed for the immunocytochemical detection of either PR or ER␣. Immunohistochemical procedures were performed using mounted or free-floating sections through the rostral-caudal extent of the hypothalamus. Sections were preincubated with 0.3% H 2 O 2 for 15 min and then permeabilized with 0.5% Triton X-100 in PBS for 20 min. To reduce nonspecific reactions, sections were treated with 1.5% normal serum from the species of the secondary antibody. Selected sections were incubated overnight at 4 C with one of the following antisera: rabbit antimouse SF-1 (1:1500), rabbit anti-ER␣ (C1355, 1:10,000; Upstate Biotechnology, Lake Placid, NY), rabbit anti-PR (A0098, 1:50; DakoCytomation, Glostrup, Denmark), rabbit anti-tyrosine hydroxylase (1:500l; Chemicon, Temecula, CA), or rabbit anti-GnRH (1:10,000; National Hormone and Pituitary Program). After washes in PBS, the sections were incubated with fluorescein-conjugated secondary antibody or biotinylated secondary antibody for 1 h at room temperature and developed using the Vectastain ABC detection system. Sections then were rinsed three times in PBS for 10 min and mounted. All photomicrographic images were captured on a Zeiss A1 microscope (Zeiss, Oberkochen, Germany) with video capture and were imported into Photoshop.
Estrogen priming
Experiments were performed on age-matched SF-1 KO nCre;F/Ϫ and WT controls according to the protocol with some modifi-cation (20) . All mice were ovariectomized at 6 wk of age, and priming was started 7 d later. For PR induction experiments, all mice were injected sc with EB (1 g/mouse in sesame oil; Sigma) or vehicle control for 5 d. For lordosis experiments, mice were injected with EB at 10 g/mouse for 2 consecutive days.
Female sexual behavior test
Estrogen-primed mice were injected with progesterone (500 g in 100 l sesame oil) 44 h after the last E2 injection. Four hours after progesterone injection, behavioral tests were performed. All behavioral tests were performed during the dark phase under dim red illumination. Mice, WT (n ϭ 11 for 2-month-old mice; n ϭ 7 for 6-month-old mice) and SF-1 KO nCre;F/Ϫ (n ϭ 11 for 2-month-old mice; n ϭ 7 for 6-monthold mice), were individually housed and maintained on a 12-h light, 12-h light cycle (lights off at noon). All tests were performed at 2 h after lights off. For female sexual behavioral test, sexually experienced WT male mice (12-16 wk old) were placed individually into experimental cages (37 ϫ 15.5 ϫ 17 cm) as a stimulus male 1 d before the experiment. A female from each of the SF-1 KO nCre;F/Ϫ and WT groups was placed separately into each experimental cage with a male and mated for 15 min. Then these two female mice were switched to the second male mouse and tested for an additional 15 min to reduce the variation of male mouse. Each female received four sexual behavior tests with an interval of 5-7 d for each test. The lordosis responses by the females were counted from video recording, and the responses to male mounts or intromissions were measured as described (58), Briefly, scores of totally unreceptive (score 0), proceptive/still posture without any extension of legs (score 0.1), proceptive/still posture with extension of legs (score 0.5), and receptive lordosis posture with dorsiflexion of the vertebral column (scores 1-3) were examined. Female responses with a score of 1 or higher were considered as lordosis response for the calculation of lordosis quotient (number lordosis/number of mounts). For the male sexual behavioral test, gonadally intact male WT (n ϭ 12) and SF-1 KO nCre;F/Ϫ (n ϭ 12) mice were used. Male mice were tested with WT female mice. All females were ovariectomized and estrogen primed 48 h before the test. Progesterone (500 g) was sc injected 4 -5 h before test to ensure high sexual receptivity. The numbers of mounts, intromissions, and ejaculations by the males were videotaped for further analysis (59) .
